[R01] A precision therapy approach to red cell transfusion for sickle cell disease
Ente: National Heart Lung and Blood Institute
Scadenza: 2029-04-30
Importo max: $779,589
Paese: US
Descrizione
ABSTRACT
Red blood cell transfusion remains a life-saving therapy for patients with sickle cell disease (SCD). A major
problem is the high rate of alloimmunization (antibody formation against transfused red cells) that occurs in
transfused patients with SCD. Alloimmunization leads to delays in care,
Settori: National Heart Lung and Blood Institute
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.